Superior Glenohumeral Translation in Patients With Degenerative Rotator Cuff Tears
NCT ID: NCT03717571
Last Updated: 2022-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
21 participants
OBSERVATIONAL
2018-10-04
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Load-induced Changes in Glenohumeral Translation in Patients With Rotator Cuff Tear
NCT04819724
Outcomes After Repair of Acute Rotator Cuff Tears
NCT01140230
Internal Rotation Deficit of the Glenohumeral Joint in Advanced-level Handball Players
NCT02011243
Ultrasound as a Diagnostic Tool for Rotator Cuff Tears
NCT01242761
Ability of Rotator Cuff Muscle Strength Levels, Assessed by Isokinetic Dynamometry, to Predict Return to Sport After Shoulder Stabilization Surgery by Open Latarjet Procedure
NCT06602713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will complete the health questionnaire and reflective markers and electromyographic sensors will be placed on anatomical landmarks and shoulder muscles, respectively, before loaded and unloaded abduction and flexion arm movements will be performed. Centre of rotation of both shoulders will be calculated to determine glenohumeral translation. This parameter will be compared between patient groups and control subjects using linear mixed models with group membership and load as fixed factor and subject as random factor. The critical shoulder angle will be included as covariate into the model to detect a potential modulating role of this factor on glenohumeral translation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
age and sex matched healthy control persons
Glenohumeral translation assessment
amount of glenohumeral translation under load
isolated tear
patients with isolated complete supraspinatus muscle tear
Glenohumeral translation assessment
amount of glenohumeral translation under load
combined tear
patients with complete supraspinatus muscle tear and either partial infraspinatus muscle tear or partial subscapularis muscle tear
Glenohumeral translation assessment
amount of glenohumeral translation under load
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glenohumeral translation assessment
amount of glenohumeral translation under load
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Degenerative complete supraspinatus muscle tear or complete supraspinatus muscle tear and either partial infraspinatus muscle tear or partial subscapularis muscle tear
* Unilateral rotator cuff tear
• 45 years ≤ age ≤ 65 years
Exclusion Criteria
* Incomplete supraspinatus muscle tear
* Tears in more than two rotator cuff muscles
* Prior conservative treatment or surgery of the ipsilateral upper extremity
* Clinical history of the contralateral glenohumeral joint
* Range of motion \< 90° in abduction and flexion
* Neuromuscular disorders affecting upper limb movement
* Additional pathologies that influence the mobility of the shoulder joints
* Inability to provide informed consent
45 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annegret Mündermann, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, Canton of Basel-City, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKNZ 2018-01692
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.